AAPL299.43+2.42 (+0.81%) ▲|ABBV234.34+4.33 (+1.88%) ▲|ABT90.27+2.44 (+2.77%) ▲|ACN126.48+1.65 (+1.32%) ▲|ADBE196.81+1.91 (+0.98%) ▲|AMAT582.66-57.52 (-8.99%) ▼|AMD521.69-29.94 (-5.43%) ▼|AMGN347.21+2.49 (+0.72%) ▲|AMT176.94+0.51 (+0.29%) ▲|AMZN234.09+1.30 (+0.56%) ▲|AVGO380.98-11.16 (-2.84%) ▼|AXP337.82-0.26 (-0.08%) ▼|BA218.75-2.08 (-0.94%) ▼|BAC57.84+0.47 (+0.82%) ▲|BKNG167.94+0.17 (+0.10%) ▲|BLK1,030.89-20.85 (-1.98%) ▼|BMY55.38+0.68 (+1.24%) ▲|BNY147.98+1.54 (+1.05%) ▲|BRK-B493.71+5.02 (+1.03%) ▲|C145.82+0.15 (+0.10%) ▲|CAT986.47-35.82 (-3.50%) ▼|CL90.92+2.25 (+2.54%) ▲|CMCSA22.78+0.46 (+2.04%) ▲|COF199.94-0.76 (-0.38%) ▼|COP110.10+0.40 (+0.36%) ▲|COST961.91+10.56 (+1.11%) ▲|CRM152.59+2.47 (+1.65%) ▲|CSCO119.59-1.94 (-1.60%) ▼|CVS101.82+0.52 (+0.51%) ▲|CVX175.65+0.59 (+0.34%) ▲|DE598.23-0.36 (-0.06%) ▼|DHR178.17-0.03 (-0.01%) ▼|DIS103.11+0.66 (+0.64%) ▲|DUK125.20+1.68 (+1.36%) ▲|EMR144.49-5.72 (-3.81%) ▼|FDX322.87-5.91 (-1.80%) ▼|GD348.01+4.65 (+1.35%) ▲|GE357.11+1.99 (+0.56%) ▲|GEV1,051.83-75.76 (-6.72%) ▼|GILD126.09+1.22 (+0.97%) ▲|GM79.48-0.96 (-1.19%) ▼|GOOG346.16-2.62 (-0.75%) ▼|GOOGL346.70-2.86 (-0.82%) ▼|GS1,099.85-6.52 (-0.59%) ▼|HD327.00+0.38 (+0.12%) ▲|HON224.81-3.31 (-1.45%) ▼|IBM265.24+13.02 (+5.16%) ▲|INTC135.87-5.07 (-3.60%) ▼|INTU260.03+2.26 (+0.87%) ▲|ISRG399.69-3.27 (-0.81%) ▼|JNJ235.47+4.18 (+1.81%) ▲|JPM334.79+3.31 (+1.00%) ▲|KO80.15+0.62 (+0.78%) ▲|LIN518.02+1.31 (+0.25%) ▲|LLY1,100.45-1.63 (-0.15%) ▼|LMT500.55+6.95 (+1.41%) ▲|LOW214.97+0.57 (+0.27%) ▲|LRCX368.16-41.39 (-10.11%) ▼|MA487.83+3.74 (+0.77%) ▲|MCD272.33+2.23 (+0.82%) ▲|MDLZ60.76+1.25 (+2.09%) ▲|MDT80.40+1.13 (+1.43%) ▲|META564.13+0.28 (+0.05%) ▲|MMM162.64-0.58 (-0.36%) ▼|MO71.09+1.58 (+2.27%) ▲|MRK118.26+2.78 (+2.41%) ▲|MS226.68-0.42 (-0.18%) ▼|MSFT374.62+7.28 (+1.98%) ▲|MU1,084.53-126.85 (-10.47%) ▼|NEE86.68+0.60 (+0.69%) ▲|NFLX72.69-0.19 (-0.26%) ▼|NKE42.42-0.77 (-1.78%) ▼|NOW96.71+3.70 (+3.98%) ▲|NVDA200.95-7.71 (-3.69%) ▼|ORCL170.02-5.06 (-2.89%) ▼|PEP141.65+0.94 (+0.67%) ▲|PFE24.87-0.21 (-0.84%) ▼|PG150.78+3.10 (+2.10%) ▲|PLTR118.58-0.92 (-0.77%) ▼|PM178.41+5.24 (+3.02%) ▲|QCOM199.77-22.13 (-9.97%) ▼|RTX183.96+2.13 (+1.17%) ▲|SBUX99.96-0.19 (-0.19%) ▼|SCHW92.83+0.80 (+0.87%) ▲|SO94.82+1.39 (+1.48%) ▲|SPG216.89+2.32 (+1.08%) ▲|T22.61+0.51 (+2.29%) ▲|TMO464.96+0.95 (+0.20%) ▲|TMUS182.64+2.58 (+1.43%) ▲|TSLA384.84-20.21 (-4.99%) ▼|TXN304.90-27.38 (-8.24%) ▼|UBER70.45-0.99 (-1.38%) ▼|UNH404.19-2.50 (-0.61%) ▼|UNP261.09+1.18 (+0.45%) ▲|UPS106.43-0.81 (-0.76%) ▼|USB59.60+0.92 (+1.57%) ▲|V330.90+4.30 (+1.32%) ▲|VZ46.09+0.73 (+1.60%) ▲|WFC84.02+0.18 (+0.21%) ▲|WMT119.63+2.45 (+2.09%) ▲|XOM139.47+1.00 (+0.72%) ▲|AAPL299.43+2.42 (+0.81%) ▲|ABBV234.34+4.33 (+1.88%) ▲|ABT90.27+2.44 (+2.77%) ▲|ACN126.48+1.65 (+1.32%) ▲|ADBE196.81+1.91 (+0.98%) ▲|AMAT582.66-57.52 (-8.99%) ▼|AMD521.69-29.94 (-5.43%) ▼|AMGN347.21+2.49 (+0.72%) ▲|AMT176.94+0.51 (+0.29%) ▲|AMZN234.09+1.30 (+0.56%) ▲|AVGO380.98-11.16 (-2.84%) ▼|AXP337.82-0.26 (-0.08%) ▼|BA218.75-2.08 (-0.94%) ▼|BAC57.84+0.47 (+0.82%) ▲|BKNG167.94+0.17 (+0.10%) ▲|BLK1,030.89-20.85 (-1.98%) ▼|BMY55.38+0.68 (+1.24%) ▲|BNY147.98+1.54 (+1.05%) ▲|BRK-B493.71+5.02 (+1.03%) ▲|C145.82+0.15 (+0.10%) ▲|CAT986.47-35.82 (-3.50%) ▼|CL90.92+2.25 (+2.54%) ▲|CMCSA22.78+0.46 (+2.04%) ▲|COF199.94-0.76 (-0.38%) ▼|COP110.10+0.40 (+0.36%) ▲|COST961.91+10.56 (+1.11%) ▲|CRM152.59+2.47 (+1.65%) ▲|CSCO119.59-1.94 (-1.60%) ▼|CVS101.82+0.52 (+0.51%) ▲|CVX175.65+0.59 (+0.34%) ▲|DE598.23-0.36 (-0.06%) ▼|DHR178.17-0.03 (-0.01%) ▼|DIS103.11+0.66 (+0.64%) ▲|DUK125.20+1.68 (+1.36%) ▲|EMR144.49-5.72 (-3.81%) ▼|FDX322.87-5.91 (-1.80%) ▼|GD348.01+4.65 (+1.35%) ▲|GE357.11+1.99 (+0.56%) ▲|GEV1,051.83-75.76 (-6.72%) ▼|GILD126.09+1.22 (+0.97%) ▲|GM79.48-0.96 (-1.19%) ▼|GOOG346.16-2.62 (-0.75%) ▼|GOOGL346.70-2.86 (-0.82%) ▼|GS1,099.85-6.52 (-0.59%) ▼|HD327.00+0.38 (+0.12%) ▲|HON224.81-3.31 (-1.45%) ▼|IBM265.24+13.02 (+5.16%) ▲|INTC135.87-5.07 (-3.60%) ▼|INTU260.03+2.26 (+0.87%) ▲|ISRG399.69-3.27 (-0.81%) ▼|JNJ235.47+4.18 (+1.81%) ▲|JPM334.79+3.31 (+1.00%) ▲|KO80.15+0.62 (+0.78%) ▲|LIN518.02+1.31 (+0.25%) ▲|LLY1,100.45-1.63 (-0.15%) ▼|LMT500.55+6.95 (+1.41%) ▲|LOW214.97+0.57 (+0.27%) ▲|LRCX368.16-41.39 (-10.11%) ▼|MA487.83+3.74 (+0.77%) ▲|MCD272.33+2.23 (+0.82%) ▲|MDLZ60.76+1.25 (+2.09%) ▲|MDT80.40+1.13 (+1.43%) ▲|META564.13+0.28 (+0.05%) ▲|MMM162.64-0.58 (-0.36%) ▼|MO71.09+1.58 (+2.27%) ▲|MRK118.26+2.78 (+2.41%) ▲|MS226.68-0.42 (-0.18%) ▼|MSFT374.62+7.28 (+1.98%) ▲|MU1,084.53-126.85 (-10.47%) ▼|NEE86.68+0.60 (+0.69%) ▲|NFLX72.69-0.19 (-0.26%) ▼|NKE42.42-0.77 (-1.78%) ▼|NOW96.71+3.70 (+3.98%) ▲|NVDA200.95-7.71 (-3.69%) ▼|ORCL170.02-5.06 (-2.89%) ▼|PEP141.65+0.94 (+0.67%) ▲|PFE24.87-0.21 (-0.84%) ▼|PG150.78+3.10 (+2.10%) ▲|PLTR118.58-0.92 (-0.77%) ▼|PM178.41+5.24 (+3.02%) ▲|QCOM199.77-22.13 (-9.97%) ▼|RTX183.96+2.13 (+1.17%) ▲|SBUX99.96-0.19 (-0.19%) ▼|SCHW92.83+0.80 (+0.87%) ▲|SO94.82+1.39 (+1.48%) ▲|SPG216.89+2.32 (+1.08%) ▲|T22.61+0.51 (+2.29%) ▲|TMO464.96+0.95 (+0.20%) ▲|TMUS182.64+2.58 (+1.43%) ▲|TSLA384.84-20.21 (-4.99%) ▼|TXN304.90-27.38 (-8.24%) ▼|UBER70.45-0.99 (-1.38%) ▼|UNH404.19-2.50 (-0.61%) ▼|UNP261.09+1.18 (+0.45%) ▲|UPS106.43-0.81 (-0.76%) ▼|USB59.60+0.92 (+1.57%) ▲|V330.90+4.30 (+1.32%) ▲|VZ46.09+0.73 (+1.60%) ▲|WFC84.02+0.18 (+0.21%) ▲|WMT119.63+2.45 (+2.09%) ▲|XOM139.47+1.00 (+0.72%) ▲|
20.6 C
New York
Tuesday, June 23, 2026

Tag: devices

Medtronic secures CE Mark for MiniMed™ 780G System for insulin-requiring people with diabetes including expanded indications in children as young as two, during pregnancy,...

GALWAY, Ireland, July 21, 2025 /PRNewswire/ -- Medtronic plc (NYSE: MDT), a global leader in medical technology, today announced CE (Conformité Européenne) Mark in...

Mission Media AI Partners with VSiN to Lead Advertising Sales Across Premium Sports Network

Mission Media AI to lead advertising sales for VSiN, The Sports Betting Network.

West Welcomes Robert McMahon as Incoming Chief Financial Officer

EXTON, Pa., July 21, 2025 /PRNewswire/ -- West Pharmaceutical Services, Inc. (NYSE: WST), a global leader in innovative solutions for injectable drug administration, today announced...

KOSPET Launches Magic Series Smartwatches, Designed for Daily Motion and Urban Style

SHENZHEN, China, July 21, 2025 /PRNewswire/ -- KOSPET today announces the launch of the all-new Magic Series, a smartwatch lineup created for users who...

GENIUS Act Passed: Dogecoin Surges to $0.27 — PaladinMining Announced Expanded Cloud Mining Contracts Amid $3,790 Daily Earning Potential

LONDON, UK, July 21, 2025 (GLOBE NEWSWIRE) -- In the wake of the newly passed GENIUS Act and a dramatic 27% surge in Dogecoin (DOGE), PaladinMining has announced an exclusive update to its mining platform, unveiling new contracts and expanded global access for crypto investors. With DOGE hitting $0.27 and open interest topping $2.65 billion, the timing couldn't be better for crypto enthusiasts looking to mine without the hassle.

AAPL SECURITIES NEWS: Did Apple Inc. (NASDAQ:AAPL) Commit Securities Fraud? Contact BFA Law by August 19 Class Action Deadline

Apple Inc. investors that lost money are notified to contact BFA Law before the August 19, 2025 securities fraud class action deadline.

Time to Mine Bitcoin on Mobile: PFMCrypto Launches App-Based BTC Cloud Mining with Daily Payouts

No Rigs, No Hassle—Just Tap, Mine, and Earn BTC from Your Phone. With PFMCrypto’s mobile-first platform, anyone can now start mining Bitcoin remotely and earn daily crypto rewards—no hardware, no technical setup.
No Rigs, No Hassle—Just Tap, Mine, and Earn BTC from Your Phone. With PFMCrypto’s mobile-first platform, anyone can now start mining Bitcoin remotely and earn daily crypto rewards—no hardware, no technical setup.

TUESDAY INVESTOR DEADLINE: Organon & Co. (OGN) Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

SAN DIEGO, July 18, 2025 /PRNewswire/ -- The law firm of Robbins Geller Rudman & Dowd LLP announces that it has filed a class...

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

European Commission Grants Conditional Approval of EZMEKLY® (mirdametinib) for the Treatment of Adult and Pediatric Patients with NF1-PN

– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –
– EZMEKLY is the first and only therapy to receive marketing authorization in the EU for both adults and children (≥2 years) with NF1-PN, a rare genetic disorder with debilitating symptoms –

Hapbee Reports First-Ever Quarterly Profit in Q2 2025 and Achieves Third Consecutive Quarter of Growth

Strong top-line gains, reduced expenditures, and improved gross margins result in milestone quarter
Strong top-line gains, reduced expenditures, and improved gross margins result in milestone quarter 

Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR of 4.3% | Exclusive Report by The Insight Partners

NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global preservative-free eye drops market is growing...

Preservative-Free Eye Drops Market Size to reach US$1.67 billion in 2031 | CAGR of 4.3% | Exclusive Report by The Insight Partners

NEW YORK, July 18, 2025 /PRNewswire/ -- According to a new comprehensive report from The Insight Partners, the global preservative-free eye drops market is growing...

Vascular Access Devices Company Evaluation Report 2025 | Becton Dickinson, Teleflex, and ICU Medical Strengthen Global Leadership Through Strategic Acquisitions and Product Innovation

The Vascular Access Devices Market Companies Quadrant delivers a thorough analysis of the global vascular access devices sector. Highlighting prominent players, innovations, and trends, it identifies the top 25 companies as quadrant leaders among over 100 evaluated. Vascular access devices (VADs), crucial for treatments like chemotherapy and dialysis, are set to grow from USD 5.99 billion in 2024 to USD 9.05 billion by 2030 at a 7.1% CAGR, fueled by rising demand and investments despite a skilled professional shortage. Key players include Beckton Dickinson, Teleflex, and ICU Medical, known for expanding portfolios through strategic acquisitions and innovations. The quadrant evaluates companies based on revenue, growth strategies, and product footprint across device types and applications.
The Vascular Access Devices Market Companies Quadrant delivers a thorough analysis of the global vascular access devices sector. Highlighting prominent players, innovations, and trends, it identifies the top 25 companies as quadrant leaders among over 100 evaluated. Vascular access devices (VADs), crucial for treatments like chemotherapy and dialysis, are set to grow from USD 5.99 billion in 2024 to USD 9.05 billion by 2030 at a 7.1% CAGR, fueled by rising demand and investments despite a skilled professional shortage. Key players include Beckton Dickinson, Teleflex, and ICU Medical, known for expanding portfolios through strategic acquisitions and innovations. The quadrant evaluates companies based on revenue, growth strategies, and product footprint across device types and applications.

- A word from our sponsors -

spot_img

Newsletter Signup

Name(Required)
Email(Required)
Privacy(Required)
This field is for validation purposes and should be left unchanged.
HomeTagsDevices